GlaxoSmithKline (GSK)

44.75 -0.31  -0.69%  Feb 10, 11:00PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch

GlaxoSmithKline Current Ratio: 1.25

Get Interactive Chart for


of


None selected
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Copy the code below and paste
into the embed destination.
  Done
Attention OK

GSK Current Ratio Rankings

Overall 33rd percentile 3034 of 4546
Sector 10th percentile 465 of 518 in Healthcare
Industry 11th percentile 23 of 26 in Drug Manufacturers - Major

GSK Current Ratio Range, Past 5 Years

Minimum 0.78 Dec 1995
Maximum 2.44 Dec 1994
Average

About Current Ratio

The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. Current assets are cash and any assets expected to be converted into cash within the next year. The ratio illustrates a company's ability to remain solvent.

A current ratio of 1 means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning that it has twice as many current assets as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.
Learn More

You may also be interested in these GSK related companies

Display in Live Stream: Done
Options

GSK News

Anticipation
Feb 08, 6:00PM
Amgen Upped to Outperform
Feb 08, 1:45PM
Interesting to see $GSK boasting about how it is repatriates its cash from European operations so fast these days. Probably a wise move.
about 4 days ago by bradloncar
$GSK IR on Twitter. Smart example. &quot;GSK to announce 2011 year-end results [today] at noon GMT. We&#39;ll be using the hashtag #GSKFY11&quot;
about 5 days ago by BHSMITH
GlaxoSmithKline (GSK) Reports Mixed Q4 Results
Feb 07, 7:04AM Street Insider
$ANAC reports partner GlaxoSmithKline $GSK has voluntarily paused enrollment of ongoing GSK &#39;052 Phase 1, 2 Clinical Trials; ANAC halted
about 6 days ago by Street_Insider
$TEVA buying opportunity here $PFE $LLY $GSK $NVS $GILD
about 9 days ago by MJT
The Best Healthcare Dividend Stocks With Fastest Earnings Growth + http://stks.co/2CgH + $GSK $VIVO $NVS $KNSY $NDZ $PETS $ABT $JNJ $LNCR
about 10 days ago by DividendYield
$TEVA strongest pharma $PFE $LLY $GSK $NVS $WPI
about 11 days ago by MJT
$RDY $GSK Generic Arixtra Upside-&gt; http://stks.co/28WZ
about 15 days ago by imhobutdydd
$RDY $GSK Generic Arixtra Upside
about 15 days ago by imhobutdydd
Drastic day for healthcare, esp. with pneumonia-deaths in clinical trials! http://stks.co/1qHP $THRX $BMY $GSK $INHX $IDIX
about 34 days ago by juliat333
HIGH $PUT VOLU $MDCO 9082% $INHX 4200% $PWRD 1772% $TDG 1582% $QCOR 1025% $JNY 725% $GSK 598% $HLS 506% $ACHN 445% $IDIX 444%
about 34 days ago by livevol_pro
$HGSi &amp; $GSK buyout news continued older news on yahoo board...
about 37 days ago by jan
$GSK/$HGSI read over on forum on yahoo...continued old news.
about 37 days ago by jan
were did you get the idea of $GSK buyout of $hgsi
about 37 days ago by superbartek
$GSK buyout of $HGSI...? Late to the news...
about 37 days ago by jan
$GSK http://stks.co/1oDf $GSK looking intersting here, looking @ Feb 46 call or ITM 45&#39;s
about 37 days ago by _TheBlackSwan_
RT @BloombergNews Drug approvals hit a seven-year high | http://stks.co/1n8c $GSK $JNJ
about 38 days ago by brittpierpoint
$CELG Spokesperson Unaware of Rumor of $GSK Offer
about 38 days ago by Benzinga
New 52-week High stocks http://stks.co/1k07 $VZ $DUK $AMGN $AMT $LLY $ABT $EP $KMI $XEL $GOOG$HCP $NEE $ECL $NVE $GSK$WYN $ALXN $DTE $PGN
about 40 days ago by ACInvestorBlog
That sums up 2011: Dividend stocks like telecoms (and utes $ED and $DUK), healthcare ($ABT $GSK et al) and discounters ($DG $FDO) thrived.
about 44 days ago by JeffReevesIP
Health care looking healthy lately, across all subsectors: $ABT $ALXN $AMGN $CNC $CVS $GSK $HUM $LLY $MRK $PFE all set 52wk highs yesterday.
about 46 days ago by JeffReevesIP
@Dostoevsky $HGSI has a few other drugs in development, in addition to a long-term relationship with $GSK
about 53 days ago by samlee22
$GSK to sell 17 OTC brands in North America to $PBH for $660M; PBH shares up 7.8% pre-open
about 54 days ago by Street_Insider
Medical-Ethical drugs group leading gains. RS @new highs. Dividend stocks $BMY $LLY $GSK $PFE are in this group. Also high flyers like $QCOR
about 55 days ago by Global_Trader
FDA Approves Axiron - Analyst Blog
Nov 24, 8:39AM Zacks

Recent Quotes

Symbol Price Chg Chg % Market Cap
GSK 44.75 -0.31 -0.69% 114.07B
OLP 17.76 -0.48 -2.63% 257.34M
ANR 21.04 -1.36 -6.07% 4.76B
BFLY 2.13 -0.00 -0.12% 52.36M
TMK 47.20 0.53 1.14% 4.81B
AMPL 0.39 0.00 0.13% 21.91M
AU 45.11 -0.82 -1.79% 17.21B
EONC 1.66 0.15 9.93% 4.75M
GFI 16.47 -0.20 -1.20% 11.93B
CVS 43.18 0.18 0.42% 56.20B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close